These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1661 related items for PubMed ID: 22928803
1. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength. Williams SA, Elliott C, Valentine J, Gubbay A, Shipman P, Reid S. Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803 [Abstract] [Full Text] [Related]
2. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy. Williams SA, Reid S, Elliott C, Shipman P, Valentine J. Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782 [Abstract] [Full Text] [Related]
3. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy. Van Campenhout A, Bar-On L, Desloovere K, Huenaerts C, Molenaers G. Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985 [Abstract] [Full Text] [Related]
4. Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study. Alexander C, Elliott C, Valentine J, Stannage K, Bear N, Donnelly CJ, Shipman P, Reid S. Dev Med Child Neurol; 2018 Nov; 60(11):1165-1171. PubMed ID: 30151852 [Abstract] [Full Text] [Related]
5. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy. Büyükavcı R, Büyükavcı MA. Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645 [Abstract] [Full Text] [Related]
6. High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy. Intiso D, Simone V, Di Rienzo F, Iarossi A, Pazienza L, Santamato A, Maruzzi G, Basciani M. NeuroRehabilitation; 2014 Sep; 34(3):515-22. PubMed ID: 24473245 [Abstract] [Full Text] [Related]
7. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence. Lukban MB, Rosales RL, Dressler D. J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573 [Abstract] [Full Text] [Related]
8. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy. Schless SH, Cenni F, Bar-On L, Hanssen B, Kalkman B, O'brien T, Aertbeliën E, Van Campenhout A, Molenaers G, Desloovere K. Dev Med Child Neurol; 2019 Jul; 61(7):783-790. PubMed ID: 30320442 [Abstract] [Full Text] [Related]
9. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin. Koman LA, Smith BP, Williams R, Richardson R, Naughton M, Griffin L, Evans P. J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186 [Abstract] [Full Text] [Related]
10. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections. Read FA, Boyd RN, Barber LA. Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160 [Abstract] [Full Text] [Related]
11. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity. Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ. Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654 [Abstract] [Full Text] [Related]
12. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences. Lorin K, Forsberg A. Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886 [Abstract] [Full Text] [Related]
13. Neurorehabilitation with versus without resistance training after botulinum toxin treatment in children with cerebral palsy: a randomized pilot study. Bandholm T, Jensen BR, Nielsen LM, Rasmussen H, Bencke J, Curtis D, Pedersen SA, Sonne-Holm S. NeuroRehabilitation; 2012 Jul; 30(4):277-86. PubMed ID: 22672941 [Abstract] [Full Text] [Related]
14. Effects of Botulinum Toxin A Injection on Ambulation Capacity in Patients with Cerebral Palsy. Çağlar Okur S, Uğur M, Şenel K. Dev Neurorehabil; 2019 May; 22(4):288-291. PubMed ID: 30095354 [Abstract] [Full Text] [Related]
15. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study. Lin YC, Lin IL, Chou TF, Lee HM. J Neuroeng Rehabil; 2016 Mar 12; 13():25. PubMed ID: 26969526 [Abstract] [Full Text] [Related]
16. Intensive therapy following upper limb botulinum toxin A injection in young children with unilateral cerebral palsy: a randomized trial. Hoare B, Imms C, Villanueva E, Rawicki HB, Matyas T, Carey L. Dev Med Child Neurol; 2013 Mar 12; 55(3):238-47. PubMed ID: 23236956 [Abstract] [Full Text] [Related]
17. The utility of shear wave elastography in the evaluation of muscle stiffness in patients with cerebral palsy after botulinum toxin A injection. Dağ N, Cerit MN, Şendur HN, Zinnuroğlu M, Muşmal BN, Cindil E, Oktar SÖ. J Med Ultrason (2001); 2020 Oct 12; 47(4):609-615. PubMed ID: 32705628 [Abstract] [Full Text] [Related]
18. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy. Crowner BE, Racette BA. Pediatr Neurol; 2008 Oct 12; 39(4):253-8. PubMed ID: 18805363 [Abstract] [Full Text] [Related]
19. Botulinum toxin for the treatment of spasticity in children: attainment of treatment goals. Weigl DM, Arbel N, Katz K, Becker T, Bar-On E. J Pediatr Orthop B; 2007 Jul 12; 16(4):293-6. PubMed ID: 17527109 [Abstract] [Full Text] [Related]
20. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy. Mirska A, Kułak W, Okurowska-Zawada B, Dmitruk E. Childs Nerv Syst; 2019 Jan 12; 35(1):141-147. PubMed ID: 30058050 [Abstract] [Full Text] [Related] Page: [Next] [New Search]